During the past decade, Health Park Pharmacy conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Health Park Pharmacy" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator, "Duke Health" with 1 trials as a collaborator and "The Emmes Company, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Health Park Pharmacy" are "Opioid Use Disorder" (1 trials) and "Opioid-use Disorder" (1 trials). Many other conditions were trialed in "Health Park Pharmacy" in a lesser frequency.

Most popular intervention types in "Health Park Pharmacy" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pharmacist-administered buprenorphine/naloxone maintenance care" (1 trials), "Pharmacy-based methadone administration and dispensing" (1 trials) and "buprenorphine/naloxone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Health Park Pharmacy" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Health Park Pharmacy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Health Park Pharmacy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Health Park Pharmacy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".